Ubiquitin-Specific Protease 10 Human
Catalog Number: B2019679 (10 ug)
Ubiquitin-Specific Protease 10 (USP10) is a deubiquitinating enzyme that regulates protein degradation and signaling by removing ubiquitin from proteins. It stabilizes proteins, influencing cellular processes like cell cycle regulation and DNA repair. USP10 interacts with key proteins involved in tumor suppression, highlighting its significance in various biological processes. This product has been used as a molecular tool for various biochemical applications. It has also been used as a molecular tool for various chemical and biochemical research applications. Custom bulk amounts of this product are available upon request.
Live Chat enquiry about this product at: Live Chat.
Product Description
Ubiquitin-Specific Protease 10 Human
Catalog number: B2019679
Lot number: Batch Dependent
Expiration Date: Batch dependent
Amount: 10 ug
Molecular Weight or Concentration: 88 kDa
Supplied as: Solution
Applications: a molecular tool for various biochemical applications
Storage: −70°C
Keywords: Ubiquitin-Specific Protease 10 Human
Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um.
References:
1. Szejtli, J. (1998). Introduction and general overview of cyclodextrin chemistry. *Chemical Reviews*, 98(5), 1743-1754.
2. Loftsson, T., & Brewster, M. E. (1996). Pharmaceutical applications of cyclodextrins. *European Journal of Pharmaceutical Sciences*, 4(2), 95-99.
3. Uekama, K., & Hirayama, F. (1996). Cyclodextrin-based controlled drug delivery systems. *Advanced Drug Delivery Reviews*, 21(2), 113-130.
4. Bender, M. L., & Komiyama, M. (1978). Cyclodextrin chemistry. *Springer-Verlag*.
5. Szejtli, J. (2000). The cyclodextrins: A versatile tool for drug delivery. *Journal of Inclusion Phenomena and Macrocyclic Chemistry*, 38(1-2), 1-12.
6. Loftsson, T., & Brewster, M. E. (2008). Cyclodextrins as functional excipients: A review. *International Journal of Pharmaceutics*, 348(1), 1-10.
7. Szejtli, J. (2004). Past, present, and future of cyclodextrin research. *Pure and Applied Chemistry*, 76(10), 1825-1835.
8. Hedges, J. B., & Hedges, J. R. (2005). The use of cyclodextrins in drug delivery systems. *Journal of Drug Delivery Science and Technology*, 15(1), 1-8.
9. Szejtli, J., & Szente, L. (2005). Elimination of the side effects of drugs by cyclodextrins. *Journal of Inclusion Phenomena and Macrocyclic Chemistry*, 53(1-4), 1-12.
10. Szejtli, J. (2006). Cyclodextrins and their inclusion complexes: An overview. *Chemical Reviews*, 106(4), 1395-1420.
(2-Hydroxypropyl)-gamma-cyclodextrin
Products Related to Ubiquitin-Specific Protease 10 Human can be found at Proteins
Additional Information
| Weight | 48 oz |
|---|---|
| Dimensions | 8 × 8 × 8 in |